Table 4.
Age- and gender-adjusted CWT-arm participant likelihood of study morbidity at Year 5, using the SBT-arm participants as reference
| Odds ratio (reference = the biennial school-based treatment arm) | CI95% | P-value | |
|---|---|---|---|
| Infection prevalence | 0.77 | 0.19, 3.06 | 0.70 |
| Wasting | 2.73 | 0.94, 7.90 | 0.06 |
| Stunting | 1.19 | 0.57, 2.47 | 0.65 |
| Anemia | 1.26 | 0.51, 3.12 | 0.62 |
| Increased PVD | 1.40 | 0.25, 7.72 | 0.70 |
| Arm difference | CI95% | P-value | |
|---|---|---|---|
| VO2 (mL/kg/min) | −0.5 | −4.8, 3.7 | 0.80 |
| Pediatric quality of life inventory | |||
| Total score | 0.7 | −7.1, 8.5 | 0.86 |
| Physical | 0.7 | −5.6, 7 | 0.82 |
| Emotional | 1.8 | −9.6, 13.2 | 0.76 |
| Social | −1.4 | −9.3, 6.6 | 0.73 |
| School | 1.4 | −6.2, 8.9 | 0.73 |
| Coefficient | CI95% | P-value | |
|---|---|---|---|
| Mean cohort-level intensity (epg) | −0.1 | −1.9, 1.7 | 0.92 |
CWT = community-wide treatment; epg = S. mansoni eggs per gram feces; PVD = portal vein diameter; VO2 max, maximal oxygen uptake as estimated by fitness testing.